351 related articles for article (PubMed ID: 28777871)
1. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
[TBL] [Abstract][Full Text] [Related]
4. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
5. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.
Cao LY; Chung JS; Teshima T; Feigenbaum L; Cruz PD; Jacobe HT; Chong BF; Ariizumi K
J Invest Dermatol; 2016 Sep; 136(9):1801-1810. PubMed ID: 27236103
[TBL] [Abstract][Full Text] [Related]
7. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells.
Lian M; Zhang J; Zhao L; Chen X; Peng Y; Wang Q; Chen S; Ma X
Front Immunol; 2019; 10():2577. PubMed ID: 31787974
[TBL] [Abstract][Full Text] [Related]
9. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
10. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis.
Lian M; Wang Q; Jiang X; Zhang J; Wei Y; Li Y; Li B; Chen W; Zhang H; Miao Q; Peng Y; Xiao X; Sheng L; Zhang W; Fang J; Tang R; Gershwin ME; Ma X
Hepatology; 2018 Nov; 68(5):1922-1936. PubMed ID: 29774578
[TBL] [Abstract][Full Text] [Related]
11. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.
Zhou Z; Lai P; Zhang S; Wang Y; Qu N; Lu D; Gao L; Xu L; Yang Y; Zhang T; Sun X; Zheng X; Liu Y; Liang H; Chen S
Biomed Res Int; 2021; 2021():6612477. PubMed ID: 33860040
[TBL] [Abstract][Full Text] [Related]
14. The clinical and prognostic significance of CD14(+)HLA-DR(-/low) myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy.
Wang D; An G; Xie S; Yao Y; Feng G
Tumour Biol; 2016 Aug; 37(8):10427-33. PubMed ID: 26846107
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
16. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis.
Li B; Lian M; Li Y; Qian Q; Zhang J; Liu Q; Tang R; Ma X
Front Immunol; 2021; 12():732102. PubMed ID: 34512667
[TBL] [Abstract][Full Text] [Related]
18. CD14
Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
[TBL] [Abstract][Full Text] [Related]
19. ILT3 (LILRB4) Promotes the Immunosuppressive Function of Tumor-Educated Human Monocytic Myeloid-Derived Suppressor Cells.
Singh L; Muise ES; Bhattacharya A; Grein J; Javaid S; Stivers P; Zhang J; Qu Y; Joyce-Shaikh B; Loboda A; Zhang C; Meehl M; Chiang DY; Ranganath SH; Rosenzweig M; Brandish PE
Mol Cancer Res; 2021 Apr; 19(4):702-716. PubMed ID: 33372059
[TBL] [Abstract][Full Text] [Related]
20. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
